| 产品详情 |
| Edit |   |
|---|
| Product Name | BMS 303141 |
|---|
| Description | Purity ~99% (HPLC). ATP citrate lyase (ACL) inhibitor (IC50 = 0.13um for human recombinant ACL); blocks lipid synthesis (IC50 = 8um in HepG2 cells). Displays no cytotoxicity up to a concentration of 50um. Lowers plasma glucose and triglycerides in a mouse model of hyperlipidemia. Orally bioavailable. Sequence: C19H15Cl2NO4S Solubility: DMSO (~10mM), Ethanol (~50mM) Molecular Weight: ~424.3 |
|---|
| Size | 10mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | BMS 303141 (ATP Citrate Lyase Inhibitor, Orally Bioavailable, 3,5-Dichloro-2-hydroxy-N-(4-methoxy[1,1'-biphenyl]-3-yl)-benzenesulfonamide) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 145663 |
|---|
| Price | |
|---|
| Order / More Info | BMS 303141 from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|